Gregory McKee

Guest Contributor
May 3, 2005

Gregory McKee has been appointed president and CEO of Victoria-based Stressgen Biotechnologies Corp, replacing Dan Korpolinski. The move comes after Stressgen withdrew its preliminary prospectus for a common share offering and a decision to sell its bioreagents business to a US firm (see New Briefs). Prior to his appointment, McKee was Stressgen’s chief financial officer and VP corporate development. Prior to joining Stressgen, he was senior director corporate development at Valentis Inc, San Francisco, and held several management positions with Genzyme Corp. McKee holds an MBA and MA from the Univ of Pennsylvania and a BA in economics from the Univ of Washington…

Other News

Events For Leaders in
Science, Tech, Innovation, and Policy

Discuss and learn from those in the know at our virtual and in-person events.

See Upcoming Events

You have 1 free article remaining.
Don't miss out - start your free trial today.

Start your FREE trial    Already a member? Log in


By using this website, you agree to our use of cookies. We use cookies to provide you with a great experience and to help our website run effectively in accordance with our Privacy Policy and Terms of Service.